Targeting dormant micrometastases: rationale, evidence to date and clinical implications
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting dormant micrometastases: rationale, evidence to date and clinical implications
Authors
Keywords
-
Journal
Therapeutic Advances in Medical Oncology
Volume 8, Issue 2, Pages 126-137
Publisher
SAGE Publications
Online
2016-01-08
DOI
10.1177/1758834015624277
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small-cell lung cancer
- (2015) Nimit Singhal et al. ANTI-CANCER DRUGS
- Identification of novel drugs to target dormant micrometastases
- (2015) Robert E. Hurst et al. BMC CANCER
- New metastatic model of human small-cell lung cancer by orthotopic transplantation in mice
- (2015) Shuichi Sakamoto et al. CANCER SCIENCE
- The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial
- (2015) Linda Dirven et al. EUROPEAN JOURNAL OF CANCER
- A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation — An NRG Oncology/Gynecologic Oncology Group study
- (2015) Robert L. Coleman et al. GYNECOLOGIC ONCOLOGY
- A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: A trial of the Princess Margaret, Chicago and California Phase II Consortia
- (2015) H. Hirte et al. GYNECOLOGIC ONCOLOGY
- A phase II evaluation of selumetinib (AZD6244, ARRY-142886), a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
- (2015) Robert L. Coleman et al. GYNECOLOGIC ONCOLOGY
- A phase II trial of trebananib (AMG 386; IND#111071), a selective angiopoietin 1/2 neutralizing peptibody, in patients with persistent/recurrent carcinoma of the endometrium: An NRG/Gynecologic Oncology Group trial
- (2015) Kathleen N. Moore et al. GYNECOLOGIC ONCOLOGY
- Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study 0229N
- (2015) Vicky Makker et al. GYNECOLOGIC ONCOLOGY
- A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
- (2015) David Bender et al. GYNECOLOGIC ONCOLOGY
- Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial
- (2015) Jean-Pascal H Machiels et al. LANCET ONCOLOGY
- Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
- (2015) Alexander M M Eggermont et al. LANCET ONCOLOGY
- Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer
- (2015) Jason B. Ross et al. NATURE CELL BIOLOGY
- Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes
- (2015) Ignazio Caruana et al. NATURE MEDICINE
- Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)
- (2015) Andrew B. Lassman et al. NEURO-ONCOLOGY
- Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
- (2015) Sandra M. Swain et al. NEW ENGLAND JOURNAL OF MEDICINE
- The emerging molecular machinery and therapeutic targets of metastasis
- (2015) Yutong Sun et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer
- (2015) Arjun V. Balar et al. UROLOGIC CLINICS OF NORTH AMERICA
- Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy
- (2015) Hilary A. Kenny et al. Nature Communications
- A six gene expression signature defines aggressive subtypes and predicts outcome in childhood and adult acute lymphoblastic leukemia
- (2015) Jin Wang et al. Oncotarget
- EMT, CTCs and CSCs in tumor relapse and drug-resistance
- (2015) Abhisek Mitra et al. Oncotarget
- Investigating Breast Cancer Cell Behavior Using Tissue Engineering Scaffolds
- (2015) Khadidiatou Guiro et al. PLoS One
- Spontaneous dormancy of metastatic breast cancer cells in an all human liver microphysiologic system
- (2014) S E Wheeler et al. BRITISH JOURNAL OF CANCER
- The Inherent Premise of Immunotherapy for Cancer Dormancy
- (2014) M. H. Manjili CANCER RESEARCH
- Cancer Cell Dormancy in Novel Mouse Models for Reversible Pancreatic Cancer: A Lingering Challenge in the Development of Targeted Therapies
- (2014) Wan-Chi Lin et al. CANCER RESEARCH
- Overdetection of Recurrence after Radical Prostatectomy: Estimates Based on Patient and Tumor Characteristics
- (2014) J. Xia et al. CLINICAL CANCER RESEARCH
- Cocultures of Mesenchymal Stem Cells and Endothelial Cells As Organotypic Models of Prostate Cancer Metastasis
- (2014) Mark S. K. Chong et al. MOLECULAR PHARMACEUTICS
- Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
- (2014) Andrea Viale et al. NATURE
- Development and Characterization of a Preclinical Model of Breast Cancer Lung Micrometastatic to Macrometastatic Progression
- (2014) Lora C. Bailey-Downs et al. PLoS One
- A Novel Model of Dormancy for Bone Metastatic Breast Cancer Cells
- (2013) R. Marlow et al. CANCER RESEARCH
- Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells
- (2013) Lara H. El Touny et al. JOURNAL OF CLINICAL INVESTIGATION
- The perivascular niche regulates breast tumour dormancy
- (2013) Cyrus M. Ghajar et al. NATURE CELL BIOLOGY
- Suppression and Activation of the Malignant Phenotype by Extracellular Matrix in Xenograft Models of Bladder Cancer: A Model for Tumor Cell “Dormancy”
- (2013) Robert E. Hurst et al. PLoS One
- Mechanisms of Metastatic Tumor Dormancy
- (2013) Mary Osisami et al. Journal of Clinical Medicine
- "A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies"
- (2012) Carolyn G Marsden et al. BMC CANCER
- Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients
- (2012) Yang Yang et al. CANCER
- Why does cancer therapy lack effective anti-metastasis drugs?
- (2012) Georg F. Weber CANCER LETTERS
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
- (2012) Haoqiang Ying et al. CELL
- Effect of Inhibition of the Lysophosphatidic Acid Receptor 1 on Metastasis and Metastatic Dormancy in Breast Cancer
- (2012) Jean-Claude A. Marshall et al. JNCI-Journal of the National Cancer Institute
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
- (2012) Christina Davies et al. LANCET
- Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
- (2012) Ryung S. Kim et al. PLoS One
- VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast Progenitors
- (2011) Xin Lu et al. CANCER CELL
- Histone Deacetylase Inhibitors Induce Growth Arrest and Differentiation in Uveal Melanoma
- (2011) S. Landreville et al. CLINICAL CANCER RESEARCH
- The metastatic microenvironment: Brain-residing melanoma metastasis and dormant micrometastasis
- (2011) Sivan Izraely et al. INTERNATIONAL JOURNAL OF CANCER
- Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
- (2011) Aya Kobayashi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Molecular mechanisms underlying tumor dormancy
- (2010) Nava Almog CANCER LETTERS
- AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
- (2010) J. E. Talmadge et al. CANCER RESEARCH
- Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth
- (2010) Dalit Barkan et al. EUROPEAN JOURNAL OF CANCER
- Modeling metastasis biology and therapy in real time in the mouse lung
- (2010) Arnulfo Mendoza et al. JOURNAL OF CLINICAL INVESTIGATION
- Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia
- (2009) D. Milojkovic et al. CLINICAL CANCER RESEARCH
- Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton
- (2008) D. Barkan et al. CANCER RESEARCH
- Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis
- (2008) D. Gao et al. SCIENCE
- Ten-Year Survival and Cost Following Breast Cancer Recurrence: Estimates from SEER-Medicare Data
- (2007) Michael E. Stokes et al. VALUE IN HEALTH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now